Browse by author
Lookup NU author(s): Dr Ute JungwirthORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Introduction: Synthetic T cell receptor (TCR) engagers are cancer therapeutics that activate T cells through recognition of antigens on the tumor cell surface. Immune mobilizing monoclonal TCR against cancer (ImmTAC) are composed of the extracellular domains of the alpha and beta chains of an affinity enhanced TCR recognizing a tumor-associated antigenic peptide-MHC complex linked to an scFv fragment of an antibody against CD3e. A first-in-class ImmTAC, Tebentafusp, is approved for the treatment of metastatic uveal melanoma. Here we asked how ImmTACs activate human primary cytotoxic T lymphocytes (CTL) in response to antigen presenting tumor target cells. Methods: We used a recently established experimental strategy to generate active and matched suppressed CTL in vitro. ResultsL ImmTACs could elicit tumor cell cytolysis in response to endogenous antigen presentation by both active and suppressed CTL, but much less so IFNg secretion, in a manner dependent on the engager affinity for CD3e. ImmTACs did so by enhancing the efficient execution of subcellular CTL polarization steps required for effective cytolysis and could trigger calcium signaling. Conclusion: These data establish that ImmTACs are powerful inducers of CTL cytotoxicity and do so with a comparable efficacy and mechanism as direct engagement of a TCR by peptide-MHC. ImmTACs retain this capability under suppressive conditions comparable to those in the tumor microenvironment.
Author(s): Huynh L, Aljohani A, Alsubaiti A, Grant T, Chapman A, Phillips G, Chamberlain J, Hayward-Wills A, Jungwirth U, Salio M, Holland CJ, Wülfing C
Publication type: Article
Publication status: Published
Journal: Immunotherapy Advances
Year: 2026
Pages: Epub ahead of print
Online publication date: 14/08/2026
Acceptance date: 30/07/2026
Date deposited: 14/08/2026
ISSN (electronic): 2732-4303
Publisher: Oxford University Press
URL: https://doi.org/10.1093/immadv/ltag020
DOI: 10.1093/immadv/ltag020
Data Access Statement: Raw data are available upon request.
Altmetrics provided by Altmetric
